Retatrutide Protocol Guide 2026: Dosing, Titration, Side Effects, Week-by-Week

A standalone beginner protocol for retatrutide — Eli Lilly's triple GLP-1/GIP/glucagon agonist. Dose math, week-by-week titration, side-effect management, realistic expectations, and where to source research-grade material.

what retatrutide actually is

Retatrutide is a long-acting peptide agonist of three gut-hormone receptors: GLP-1, GIP, and glucagon. It's Eli Lilly's follow-on to tirzepatide — the same dual-agonist design plus a third receptor (glucagon) that adds direct metabolic-rate elevation and hepatic fat clearance.

The Phase 2 trial (Jastreboff et al. 2023, NEJM, 338 adults with obesity) PMID: 37356017 tested four weekly doses over 48 weeks:

The Phase 3 TRIUMPH program is in flight — readout expected late 2026. FDA approval likely 2027+.

the dose schedule

The Phase 2 trial used a 4-week-per-step titration from a 2 mg starting dose. Research-use users have largely converged on the same pattern:

Some conservative protocols start at 1 mg for week 1-2 to test for severe nausea, then jump to 2 mg by week 3. The Phase 2 trial's 2 mg starting dose was well-tolerated by ~85% of participants — most people don't need the half-step.

reconstitution + injection

Retatrutide typically ships as a lyophilized powder in 10 mg vials. Standard reconstitution:

1. Use bacteriostatic water for injection (BAC-WFI) — not sterile water. BAC has 0.9% benzyl alcohol that keeps the vial stable 30 days refrigerated.
2. Reconstitute with 1.0 to 2.0 mL BAC water depending on your dose precision needs. At 1.0 mL: each 10 units on a U-100 syringe = 1 mg. At 2.0 mL: each 20 units = 1 mg.
3. Swirl gently — don't shake. Shaking denatures the peptide. Inverting the vial slowly is fine.
4. Refrigerate after reconstitution. Stable 4-30 days depending on storage.
5. Inject subcutaneously — abdomen, thigh, or upper arm. Rotate sites weekly.

Use the BHG reconstitution calculator to calculate the exact units for your specific vial + BAC volume + target dose.

week-by-week protocol

Weeks 1-4: 2 mg weekly

The ramp-on phase. Expected:

• Mild nausea in the first 24-48 hours after injection (5-10/10 users)
• Reduced appetite — most users eat 200-400 calories less per day without trying
• Mild GI changes (constipation or loose stools, varies)
• Weight loss: typically 1-3 lbs in the first 4 weeks

If nausea is severe (vomiting, dehydration, can't keep food down), hold at 2 mg for 1-2 extra weeks before escalating.

Weeks 5-8: 4 mg weekly

The early acceleration phase. Expected:

• Mild-to-moderate nausea returns for 2-3 days post-injection of the first 4 mg dose
• Appetite suppression deepens noticeably
• Weight loss accelerates — typically 4-8 lbs over weeks 5-8
• Energy may dip during the GI window — eat regular small meals, don't skip meals

Weeks 9-12: 8 mg weekly

The primary therapeutic dose for most users. Expected:

• Nausea peaks again with the dose increase, then plateaus
• Strong appetite suppression — many users have to remind themselves to eat
• Weight loss continues at 1-2 lbs/week
• Body composition starts shifting visibly (waist measurement, clothes fit)

Weeks 13-24: 12 mg weekly (maintenance)

The trial-data dose. Expected:

• Side effects stabilize at a tolerable baseline (mild post-injection nausea for ~24 hours, occasional fatigue)
• Weight loss continues but slows naturally as you approach your body's new set point
• By week 24, most users have lost 15-22% of starting body weight
• Curve flattens around week 32-40 for most users

Beyond week 24

Continue 12 mg/week until weight loss has fully plateaued for 6-8 weeks. At that point, drop back to a maintenance dose (typically 4-8 mg/week) for body-composition preservation, or cycle off.

side-effect management

Common retatrutide side effects + management:

• Nausea — peaks 24-48 hours post-injection. Eat small, frequent, low-fat meals. Ginger tea + B6 25 mg helps real users. Don't fight it with caffeine.
• Constipation — drink 3L+ water, add magnesium glycinate 300-400 mg/day, prioritize fiber (chia, psyllium, vegetables).
• Fatigue — usually diet-related. Track calories — many users drop below 1200/day without realizing. Maintain 0.7-1.0 g protein per lb lean body mass.
• Heart rate elevation — +3-7 bpm during titration is normal. Resolves at steady state. If persistent or >10 bpm elevation: consult clinician.
• Injection-site reactions — minor redness/swelling in 25-40% of users. Rotate sites, use fresh needles, consider 30g insulin syringes instead of 27g.
• Hair shedding — appears 8-12 weeks in for some users, related to rapid weight loss not direct drug effect. Resolves at steady state, manage with biotin + adequate protein.

realistic expectations

What the trial actually showed:

• 24.2% mean weight loss at 12 mg over 48 weeks
• Weight-loss curve still descending at trial end (no clear plateau yet)
• ~6% of participants achieved ≥30% weight loss
• ~25% achieved ≥25% weight loss
• ~50% achieved ≥20% weight loss

Real-world research-use results often lag the trial average by 3-5% due to:

• Less consistent dosing (skipped weeks, reconstitution errors)
• Diet drift (the trial provided dietary counseling)
• Self-titration variability

A reasonable target for a real-world user: 15-20% body-weight loss at 24 weeks, 20-25% at 48 weeks if you stay disciplined on protocol + diet.

stack pairings

The most common retatrutide stack is retatrutide + tesamorelin — the Ultimate Shred Stack. Tesamorelin (a GHRH analogue) targets visceral fat directly via GH-mediated lipolysis. The combination produces faster + more aesthetic body recomp than retatrutide alone, especially for users with significant belly fat.

Other stack options:

• Retatrutide + BPC-157 — for users training hard during cut, BPC-157 supports tendon/joint recovery
• Retatrutide + electrolyte protocol — keto-style sodium/potassium/magnesium dosing during the calorie-deficit window prevents fatigue + cramping
• Retatrutide + protein-first eating — not a peptide stack, but the single biggest determinant of lean-mass preservation during loss

where to source

Retatrutide is not FDA-approved as of May 2026, so there is no pharmacy channel in the US. Research-use vendors are the only path. BHG tracks live retatrutide prices across vetted vendors on the /compound/retatrutide page — the live price comparison updates weekly.

The lowest-priced retatrutide vendor as of May 2026 is ResearchChemHQ at ~$0.16/mg via the BHG vendor link. For a 12 mg/week protocol over 48 weeks, that's ~$92 in raw molecule cost — vs $200-400/mg from premium-positioned vendors which would be $1,150-2,300 for the same protocol.

Vendor due-diligence framework

Trust scores, COA verification status, shipping speed, payment options

See vendor trust scorecard — 8+ peptide suppliers ranked

when to cycle off

Phase 2 retatrutide doesn't establish a fixed cycle length — participants ran continuous 48-week courses. Real-world common patterns:

• 24-week cycles with 8-12 weeks off — most common for body-comp users
• 48-week courses for users with significant weight to lose (>40 lbs target)
• Continuous low-dose maintenance (4-8 mg/week) for users defending a long-term weight loss

What happens when you stop:

• Appetite returns to baseline over 4-8 weeks as the peptide clears
• Weight regain risk is real if you don't adjust diet — typical regain is 30-50% of lost weight over 1 year if no behavior changes
• Users who maintain protein-first eating + resistance training during cycle-off typically retain 70-90% of lost weight

further reading

• /compound/retatrutide — live retatrutide prices across vetted vendors
• /compare/retatrutide-vs-tirzepatide — head-to-head deep-dive with full trial data
• /compare/retatrutide-vs-semaglutide — comparison vs the original GLP-1
• /blog/ultimate-shred-stack-retatrutide-tesamorelin-protocol — retatrutide + tesamorelin recomp stack
• /blog/tirzepatide-to-retatrutide-switch-protocol — if you're already on tirzepatide
• /blog/glp1-plateau-breakthrough-protocol — strategies for when any GLP-1 stalls
• /blog/how-to-read-peptide-coa — vendor COA verification framework
• /vendors/scorecard — full peptide vendor trust scorecard

No comments yet — be the first to share your thoughts!

Weekly drops, weekly research

New guides, price-drop alerts, and reader-submitted protocols. One email a week. Unsubscribe anytime.

Email addressSubscribe

No spam. Unsubscribe anytime.

Related Articles